InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Gill John. Director active across 1 company, notably Altimmune, Inc.. In total, 4 filings have been published. Breakdown: 2 buys · 1 sell. Total volume traded: €110k. Activity tracked since 12 August 2022. The latest transaction was filed on 6 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Gill John is a declarant associated with Altimmune, Inc., where he is a Director. He has 4 filings in total, and among the sampled recent filings the transactions run from 2023-07-06 to 2026-04-06, with EUR 70721 of buys and EUR 39460 of sells, and the modal transaction nature is Acquisition.